China's military has approved a coronavirus vaccine developed by its own research staff and a Chinese biotech firm, it was announced on Monday. The vaccine was given the green light for use by troops after trials proved it was both safe and effective, said CanSino Biologics, the biotech firm involved. However, its use for the time being will be restricted to military personnel, who offer a tighter medical control group than the general public. The vaccine candidate, named Ad5-nCoV, was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences. It has been in development since March. CanSino said the results showed the vaccine candidate has potential to prevent diseases caused by the coronavirus, which has killed half a million people globally. The company added that it was not yet possible to say if it could be a commercial success, which would depend on being able to produce the vaccine cheaply as well as safely.
Chinese hackers are trying to steal COVID-19 vaccine research, US authorities said Wednesday, ratcheting up tensions between the superpowers as markets slumped on warnings from the US Federal Reserve that prolonged shutdowns could cause “lasting damage”. Europe, meanwhile, pushed ahead with plans to gradually reopen for summer tourism, even as fears persist of a second wave of infections in the pandemic that has forced more than half of humanity behind closed doors in recent months. With some countries scrambling after a fresh surge in cases and the global death toll exceeding 294,000, the World Health Organization (WHO) warned Wednesday that the virus “may never go away.”